Status:
COMPLETED
Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Social Anxiety Disorder
Alcohol Use Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to treat individuals with social anxiety disorder with a Food and Drug Administration-approved medication for the treatment of social anxiety disorder, the antidepressant ...
Detailed Description
Psychiatric and alcohol use problems co-occur in a significant number of individuals seeking treatment in mental health treatment settings. However, there is a paucity of research to guide clinical pr...
Eligibility Criteria
Inclusion
- Age 18-65.
- Meets DSM-IV criteria for Social Anxiety Disorder, generalized type.
- LSAS score greater than or equal to 60.
- Reports drinking at least 15 standard drinks/week or 5 standard drinks/drinking day for men, and at least 8 standard drinks/week or 4 standard drinks/drinking day for women in the past 30 days.
- AUDIT score between 8 and 15 inclusive for men and 4 and 15 inclusive for women.
- Reports no prior medical alcohol detoxification or formal alcohol treatment including regular attendance at self-help groups.
- Treatment seeking for relief of social anxiety, not for alcohol problems.
- Endorses drinking to cope with anxiety at least 40% of the time during or before a social situation, using the Drinking to Cope survey.
- Able to provide informed consent and fill out self-rating forms in English.
Exclusion
- Drug dependence in the past 90 days on any drug besides caffeine or nicotine.
- Lifetime diagnosis of bipolar disorder or schizophrenia.
- Significant suicide risk as assessed by the SCID.
- Current use of psychotropic medications.
- Pregnancy, nursing or refusal to use effective birth control if female.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT00862212
Start Date
January 1 2009
End Date
July 1 2012
Last Update
April 23 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55454
2
Medical University of South Carolina
Charleston, South Carolina, United States, 29425